A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
Por:
Bueno C, Torres-Ruíz R, Velasco-Hernandez T, Molina O, Petazzi P, Martinez-Moreno A, Rodríguez-Cortez VC, Vinyoles M, Cantilena S, Williams O, Vega-García N, Rodriguez-Perales S, Segovia JC, Quintana-Bustamante O, Roy A, Meyer C, Marschalek R, Smith A, Milne TA, Fraga MF, Tejedor JRR and Menendez P
Publicada:
16 nov 2023
Ahead of Print:
1 nov 2023
Resumen:
Cellular ontogeny and MLL breakpoint site influence the capacity of MLL-edited CD34+ hematopoietic cells to initiate and recapitulate infant patients' features in pro-B-cell acute lymphoblastic leukemia (B-ALL). We provide key insights into the leukemogenic determinants of MLL-AF4+ infant B-ALL.
Filiaciones:
Bueno C:
Josep Carreras Leukemia Research Institute, Barcelona, Spain
Torres-Ruíz R:
CNIO, Spain
Velasco-Hernandez T:
Josep Carreras Leukemia Research Institute., Barcelona, Spain
Molina O:
Josep Carreras Leukemia Research Institute, Barcelona, Spain
Petazzi P:
Josep Carreras Leukemia Research Institute, Barcelona, Spain
Martinez-Moreno A:
Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine,, Barcelona, Spain
Rodríguez-Cortez VC:
Josep Carreras Leukemia Research Institute, Barcelona, Spain
Vinyoles M:
Josep Carreras Leukemia Research Institute, Barcelona, Spain
Cantilena S:
UCL Institute of Child Health, London, United Kingdom
Williams O:
UCL Institute of Child Health, London, United Kingdom
Vega-García N:
Haematology Laboratory, Institut de Recerca Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
Rodriguez-Perales S:
CNIO, Madrid, Spain
Segovia JC:
Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades R, MADRID, Spain
Quintana-Bustamante O:
CIEMAT/CIBERER/IIS-FJD, Madrid, Spain
Roy A:
University of Oxford, Oxford, United Kingdom
Meyer C:
DCAL, Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt/M, Germany
Marschalek R:
Goethe-University of Frankfurt/Main, Frankfurt, Germany
Smith A:
Weatherall Institute of Molecular Medicine, Oxford, United Kingdom
Milne TA:
University of Oxford, Oxford, United Kingdom
Fraga MF:
Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain
Tejedor JRR:
Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain
Menendez P:
Institut Català de Recerca i Estudis Avançats (ICREA), Spain
Green Published, hybrid
|